A new tool that enables thousands of tiny experiments to run simultaneously on a single polymer chip will let scientists study enzymes faster and more comprehensively than ever before.
Medical devices employing AI stand to benefit everyone in society, but if left unchecked, the technologies could unintentionally perpetuate sex, gender and race biases.
James Swartz has spent a dozen years refining an underappreciated biotech technique into a radical new vaccine approach that could quickly protect billions of people from the next COVID-19-level pandemic.
Injecting patients with a gel that would dissolve over several months could replace the need to administer daily or weekly shots. But to make this possible, researchers first had to create a Jello-like substance that could defy one of the fundamental laws of nature.
The new device can continuously sense levels of virtually any protein or molecule in the blood. The researchers say it could be transformative for disease detection, patient monitoring and biomedical research.
Using “lab on a chip” technology, Stanford engineers have created a microlab half the size of a credit card that can detect COVID-19 in just 30 minutes.
Stanford engineers have genetically reprogrammed the cellular machinery of yeast to create microscopic factories that convert sugars and amino acids into plant-based drugs.
Teaching students about the existential threat of a pandemic as they are living through one can help make the danger feel less hypothetical and much more real.
A technique called COSMOS will help researchers understand how our brains work and aid in the development of new drugs. The inventors have created an instructional website to help other researchers build their own relatively-inexpensive COSMOS systems.
Researchers have developed a way to combine insulin with a second hormone known as amylin, to create a two-in-one injection that could, if proven safe and effective in human trials, make it easier for diabetics to more effectively control their blood sugar levels.
